Itau Unibanco Holding S.A. boosted its stake in shares of Humana Inc (NYSE:HUM) by 92.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,943 shares of the insurance provider’s stock after purchasing an additional 1,413 shares during the quarter. Itau Unibanco Holding S.A.’s holdings in Humana were worth $730,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of HUM. Advantus Capital Management Inc lifted its holdings in shares of Humana by 1.4% in the third quarter. Advantus Capital Management Inc now owns 14,798 shares of the insurance provider’s stock valued at $3,605,000 after purchasing an additional 203 shares in the last quarter. Cadence Capital Management LLC lifted its holdings in shares of Humana by 3.6% in the third quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock valued at $1,434,000 after purchasing an additional 205 shares in the last quarter. Daiwa SB Investments Ltd. lifted its holdings in shares of Humana by 44.9% in the fourth quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after purchasing an additional 220 shares in the last quarter. HL Financial Services LLC lifted its holdings in shares of Humana by 2.1% in the fourth quarter. HL Financial Services LLC now owns 11,205 shares of the insurance provider’s stock valued at $2,780,000 after purchasing an additional 230 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in shares of Humana by 3.6% in the third quarter. Mackenzie Financial Corp now owns 6,642 shares of the insurance provider’s stock valued at $1,618,000 after purchasing an additional 232 shares in the last quarter. Institutional investors own 97.68% of the company’s stock.
Humana Inc (HUM) opened at $269.00 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.61 and a current ratio of 1.85. The stock has a market cap of $37,037.08, a P/E ratio of 23.01, a P/E/G ratio of 1.45 and a beta of 0.93. Humana Inc has a one year low of $203.36 and a one year high of $293.35.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.00 by $0.06. The business had revenue of $13.19 billion for the quarter, compared to the consensus estimate of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.34 earnings per share. research analysts forecast that Humana Inc will post 13.86 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 0.74%. This is an increase from Humana’s previous quarterly dividend of $0.40. Humana’s dividend payout ratio (DPR) is currently 9.59%.
Humana declared that its board has authorized a share buyback program on Thursday, December 14th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.
HUM has been the topic of several recent research reports. Credit Suisse Group initiated coverage on shares of Humana in a report on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 price target on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $242.00 price target (down previously from $245.00) on shares of Humana in a report on Thursday, November 9th. Morgan Stanley reduced their price target on shares of Humana from $276.00 to $270.00 and set an “overweight” rating on the stock in a report on Thursday, November 9th. BMO Capital Markets upped their price target on shares of Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a report on Friday, November 10th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $230.00 price target on shares of Humana in a report on Tuesday, December 5th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Humana presently has an average rating of “Buy” and an average target price of $270.47.
In other Humana news, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the transaction, the vice president now owns 11,557 shares of the company’s stock, valued at $2,843,484.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Brian P. Leclaire sold 1,679 shares of the stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at approximately $2,432,151.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,115 shares of company stock worth $2,501,627. 0.80% of the stock is currently owned by insiders.
COPYRIGHT VIOLATION NOTICE: “Humana Inc (HUM) Holdings Lifted by Itau Unibanco Holding S.A.” was published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thestockobserver.com/2018/02/20/humana-inc-hum-holdings-lifted-by-itau-unibanco-holding-s-a.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.